GE mosquitoes

GM mosquito OX513A ...

Oxford-based company Oxitech genetically modified the yellow fever mosquito (Aedes aegypti) to develop the GM variety OX513A. OX513A mosquitoes are genetically modified to require the antibiotic tetracycline in order to survive to adulthood. The mosquitoes are grown in the lab with tetracycline present, before adult males and females are separated.

CSO statement on the planned field release of GM mosquitos

As civil society organizations from around the world, we write to you to respectfully put forward our views on the issue of the release of genetically modified (GM) Aedes aegypti mosquitoes in Malaysia. It is not clear when such releases will occur, but given the tremendous international interest in the issue, it would be regrettable if the field trials were to be shrouded in secrecy.

Open Letter on the release of GM mosquitos in Malaysia

Many of us were among the 87 civil society organizations from around the world that sent you, in December 2010, a statement of concern regarding the field release of genetically modified (GM) Aedes aegypti mosquitoes in Malaysia. At the time, we had stated that it was not clear when such releases would occur, but given the tremendous international interest in the issue, it would be regrettable if the field trials were to be shrouded in secrecy.

Release of GM mosquito Aedes aegypti OX513A (NRE(S)609-2/1/3)

In August 2010, the Malaysian Ministry for Natural Resource and Environment announced plans to release the GM mosquito Aedes aegypti OX513A (NRE(S)609-2/1/3) and invited scientific opinions. EcoNexus submitted the following Scientific Opinion. Note: Some paragraphs have been slightly edited for better understanding for a wider audience since the original submission to the Malaysian authorities on 3 September 2010.

Subscribe to GE mosquitoes